10 Gynecologic Cancer Symptoms Women Shouldn’t Ignore
Pelvic pain and abnormal bleeding aren’t the only signs of gynecologic cancer. More than 80,000 women in the United States are diagnosed each year with a gynecologic cancer, such as cervical, endometrial (also known as uterine) or ovarian cancer.
Coping with the Side Effects of Surgery for Ovarian Cancer
Treatment for ovarian cancer usually involves surgery followed by chemotherapy. You may experience physical, emotional, and psychological side effects related to your cancer and the treatment of your specific disease. The key to proactively managing side effects begins with good communication with the healthcare team.
Hereditary Breast and Ovarian Cancer Week
In 2010, history was made with FORCE’s successful effort to pass a Congressional resolution declaring the first-ever National Hereditary Breast and Ovarian Cancer (HBOC) Week. This year's celebrations will be held September 25 through October 2, 2011.
New Treatment Options Lead to Steady Progress Against Ovarian Cancer
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease.
Ovarian Cancer – Managing the Side Effects of Treatment
by Wendy Topeka BSN, RN, OCN
When a woman hears the words “you have ovarian cancer,” it is from that very moment that a partnership begins between the woman, her family, and the doctors and nurses caring for her. This partnership is a key element in the treatment and management of ovarian cancer. It is this relationship that will help her tackle any side effect or challenge she may face related to this diagnosis.
Modified Chemotherapy Regimen Effective in Advanced Ovarian Cancer
Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a modified regimen of a standard chemotherapy drug combination.
by Thomas J. Herzog, MD, and Robert L. Coleman, MD
Women who are suspected of having ovarian cancer and women who have been diagnosed with ovarian cancer often receive a blood test to measure their CA-125 level. CA-125 is a substance found in the blood called a glycoprotein (a sugar-associated protein). It is commonly referred to as a biomarker or tumor marker because it provides information about the biological state of a disease (ovarian cancer) and is obtained by a blood sample from which a level can be measured. But it is more accurately considered a tumor associated protein because elevated CA-125 levels do not always indicate ovarian cancer, and levels can be misleading.
New Surgical Technique Shows Promising Results for Women with Cervical Cancer
A new surgical technique could allow surgeons to perform a radical hysterectomy in women with early-stage cervical cancer – with fewer complications, reduced morbidity, and a lower risk of local tumor recurrence than current surgical methods, according to an article published in The Lancet Oncology.